136 related articles for article (PubMed ID: 24981565)
1. Myasthenia gravis incidence in a general North Atlantic isolated population.
Joensen P
Acta Neurol Scand; 2014 Oct; 130(4):222-8. PubMed ID: 24981565
[TBL] [Abstract][Full Text] [Related]
2. Incidence of granulomatosis with polyangiitis (Wegener's) in Greenland and the Faroe Islands: epidemiology of an ANCA-associated vasculitic syndrome in two ethnically distinct populations in the North Atlantic area.
Faurschou M; Helleberg M; Obel N; Baslund B
Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S52-5. PubMed ID: 23663682
[TBL] [Abstract][Full Text] [Related]
3. Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa.
Mombaur B; Lesosky MR; Liebenberg L; Vreede H; Heckmann JM
Muscle Nerve; 2015 Apr; 51(4):533-7. PubMed ID: 25060190
[TBL] [Abstract][Full Text] [Related]
4. Myasthenia gravis in the county of Viborg, Denmark.
Sørensen TT; Holm EB
Eur Neurol; 1989; 29(3):177-9. PubMed ID: 2731568
[TBL] [Abstract][Full Text] [Related]
5. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
[TBL] [Abstract][Full Text] [Related]
6. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England.
Robertson NP; Deans J; Compston DA
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):492-6. PubMed ID: 9771771
[TBL] [Abstract][Full Text] [Related]
7. Myasthenia gravis: a study from India.
Singhal BS; Bhatia NS; Umesh T; Menon S
Neurol India; 2008; 56(3):352-5. PubMed ID: 18974563
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data.
Keovilayhong S; Mulliez A; Feral L; Chenaf C; Clavelou P; Moisset X; Taithe F; Poncet Megemont L
Rev Neurol (Paris); 2024 May; 180(5):451-458. PubMed ID: 38582663
[TBL] [Abstract][Full Text] [Related]
9. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
Kupersmith MJ; Latkany R; Homel P
Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands.
Niks EH; Kuks JB; Verschuuren JJ
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):417-8. PubMed ID: 17056627
[TBL] [Abstract][Full Text] [Related]
11. Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989.
Christensen PB; Jensen TS; Tsiropoulos I; Sørensen T; Kjaer M; Højer-Pedersen E; Rasmussen MJ; Lehfeldt E; de Fine Olivarius B
Neurology; 1993 Sep; 43(9):1779-83. PubMed ID: 8414031
[TBL] [Abstract][Full Text] [Related]
12. A national epidemiological study of Myasthenia Gravis in Australia.
Gattellari M; Goumas C; Worthington JM
Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of primary focal dystonia in the Faroe Islands.
Joensen P
Acta Neurol Scand; 2016 Jan; 133(1):55-60. PubMed ID: 26041438
[TBL] [Abstract][Full Text] [Related]
14. Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996-2009.
Pedersen EG; Hallas J; Hansen K; Jensen PE; Gaist D
Eur J Neurol; 2013 Feb; 20(2):309-14. PubMed ID: 22882327
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis: a higher than expected incidence in the elderly.
Aragonès JM; Bolíbar I; Bonfill X; Bufill E; Mummany A; Alonso F; Illa I
Neurology; 2003 Mar; 60(6):1024-6. PubMed ID: 12654975
[TBL] [Abstract][Full Text] [Related]
16. A nationwide epidemiological study of myasthenia gravis in Latvia.
Zieda A; Ravina K; Glazere I; Pelcere L; Naudina MS; Liepina L; Kamsa I; Kurjane N; Woodhall M; Jacobson L; Leite MI; Tandon K; Kenina V
Eur J Neurol; 2018 Mar; 25(3):519-526. PubMed ID: 29194859
[TBL] [Abstract][Full Text] [Related]
17. Myasthenia gravis in Hong Kong Chinese. 2. Paediatric disease.
Wong V; Hawkins BR; Yu YL
Acta Neurol Scand; 1992 Jul; 86(1):68-72. PubMed ID: 1519477
[TBL] [Abstract][Full Text] [Related]
18. Geographical distribution of a seropositive myasthenia gravis population.
Heldal AT; Eide GE; Gilhus NE; Romi F
Muscle Nerve; 2012 Jun; 45(6):815-9. PubMed ID: 22581533
[TBL] [Abstract][Full Text] [Related]
19. A population based epidemiological study on myasthenia gravis in Estonia.
Oöpik M; Kaasik AE; Jakobsen J
J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1638-43. PubMed ID: 14638881
[TBL] [Abstract][Full Text] [Related]
20. Juvenile myasthenia gravis in Norway: A nationwide epidemiological study.
Popperud TH; Boldingh MI; Brunborg C; Faiz KW; Heldal AT; Maniaol AH; Müller KI; Rasmussen M; Øymar K; Kerty E
Eur J Paediatr Neurol; 2017 Mar; 21(2):312-317. PubMed ID: 27666466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
